Skip to main content
SpringerLink
Log in

Clozapine Withdrawal Catatonia and Neuroleptic Malignant Syndrome: A Case Report

  • Published:
Annals of Clinical Psychiatry

Abstract

Catatonia as a clozapine withdrawal syndrome has not been documented. We report a case of excited catatonia with fever, autonomic instability, and delirium—a picture of malignant catatonia (lethal catatonia) after abrupt clozapine withdrawal. The use of conventional neuroleptics transformed the excited malignant catatonia into a stuporous state resembling neuroleptic malignant syndrome (NMS). Such a transformation of excited lethal catatonia into NMS has been described in the literature, providing support for the hypothesis that NMS is a variant of catatonia. Opinions, however, have been conflicting whether lethal catatonia and NMS are indistinguishable. We argue that NMS may be regarded as a neuroleptic-induced retarded (stuporous) subtype of malignant catatonia, clinically indistinguishable from nonneuroleptic retarded malignant catatonia but different from the excited form. To differentiate between the two subtypes of malignant catatonia would help resolve the controversy. The nosological status of excited catatonia, a poorly studied condition, remains unclear. The two subtypes of catatonia may differ in pathophysiology and responses to treatment. Clinicians should be alert to catatonia as a possible clozapine withdrawal phenomenon, and excited catatonia deserves more research attention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Shore D, Matthews S, Cott J, Jeffrey A: Clinical implications of clozapine discontinuation: report of an NIMH workshop. Schizo Bull 1995; 21:333–338

    Google Scholar 

  2. Taylor MA: Catatonia: A review of a behavioural neurologic syndrome. Neuropsychiatr, Neuropsychol Behav Neurol 1990; 3:48–72

    Google Scholar 

  3. Stauder KH: Die todliche katatonie. Arch Psychiatr Nervenkr. 1934; 102:614–634

    Google Scholar 

  4. Philbrick KL, Rummans TA: Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994; 6:1–13

    Google Scholar 

  5. Lohr JB, Wisniewski AA: Movement Disorders: A Neuropsychiatric approach. New York: Guilford, 1987

    Google Scholar 

  6. Bush G, Fink M, Dowling F, Francis A: Catatonia. I. Rating scale and standardised examination. Acta Psychiatr Scand 1996; 93:137–143

    Google Scholar 

  7. Morrison JR: Catatonia: Retarded and excited types. Arch Gen Psychiatry 1973; 28:39–41

    Google Scholar 

  8. De Leon J, Stanilla JK, White AO, Simpson GM: Anticholinergics to treat clozapine withdrawal. J Clin Psychiatry 1994; 55:3–4

    Google Scholar 

  9. Verghese C, De Leon J, Nair C, Simpson GM: Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics. Biol Psychiatry 1996; 39:135–138

    Google Scholar 

  10. Dilsaver SC, Gardos G: Antidepressant withdrawal symptoms treated with anticholinergic agents. Am J Psychiatry 1983; 140:249–251

    Google Scholar 

  11. Gardos G, Cole JO, Tarsy D: Withdrawal syndrome associated with antipsychotic drugs. Am J Psychiatry 1978; 135:1321–1324

    Google Scholar 

  12. Parsa MA, Ramirez LF, Meltzer HY: Prolonged psychotic relapse after abrupt clozapine withdrawal. J Clin Psychopharmacol 1993; 13:154–155

    Google Scholar 

  13. Alphs LD, Lee HS: Comparison of withdrawal of typical and atypical antipsychotic drugs: A case study. J Clin Psychiatry 1991; 52:346–348

    Google Scholar 

  14. Ekblom B, Erikson K, Lindstrom LH: Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 1984; 83:293–294

    Google Scholar 

  15. Luchins DJ, Freed WJ, Wyatt RJ: The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of anticholinergic drugs. Am J Psychiatry 1980; 137:1395–1398

    Google Scholar 

  16. Albucher RC, De Quardo J, Tandon R: Treatment of catatonia with an anticholinergic agent. Biol Psychiatry 1991; 29:513–514

    Google Scholar 

  17. Menza MA, Harris D: Benzodiazepines and catatonia: An overview. Biol Psychiatry 1989; 26:842–846

    Google Scholar 

  18. Mann SC, Caroff SN, Bleier HR, Welz WKR, Kling MA, Hayashida M: Lethal catatonia. Am J Psychiatry 1986; 143:1374–1381

    Google Scholar 

  19. Kurtan R, Hamill R, Shoulsm I: Neuroleptic malignant syndrome. Clin Neuropharmacol 1984; 7:109–120

    Google Scholar 

  20. Castillo E, Rubin RT, Holsboer-Trachsler E: Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:324–328

    Google Scholar 

  21. Lee WYJ: Catatonia: The tension insanity. Br J Psychiatry 1993; 163:696 (published erratum appears in Brit J Psychiatry 1994; 164:1341)

    Google Scholar 

  22. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF: Catatonic syndrome in a general psychiatric population: Frequency, clinical presentation, and response to lorazepam. J Clinical Psychiatry 1990; 51:357–362

    Google Scholar 

  23. Lee JWY: Catatonia and ECT. Aust NZ J Psychiatry 1994; 28:690–691

    Google Scholar 

  24. Hafner H, Kasper S: Akute lebensbedrohliche Katatonie: Epedemiologische und Klinische Befunde. Nervenzart 1982; 53:385–394

    Google Scholar 

  25. Ichikawa J, Meltzer HY: Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. J Pharmacol Exp Ther 1991; 256:348–357

    Google Scholar 

  26. Fricchione GL: Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry 1985; 20:304–313

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Graylands Hospital, Perth, Western Australia, Australia

    Joseph W. Y. Lee

  2. Mt Claremont, Western Australia, W.A. 6010, Australia

    Joseph W. Y. Lee

  3. Tokanui Hospital, Te Awamutu, New Zealand

    Stephen Robertson

Authors
  1. Joseph W. Y. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, J.W.Y., Robertson, S. Clozapine Withdrawal Catatonia and Neuroleptic Malignant Syndrome: A Case Report. Ann Clin Psychiatry 9, 165–169 (1997). https://doi.org/10.1023/A:1026230024656

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026230024656

Search

Navigation